RAD18 polymorphisms are associated with platinum-based chemotherapy toxicity in Chinese patients with non-small cell lung cancer

被引：0
|
作者：
Tian-qing Chu
Rong Li
Min-hua Shao
Jun-yi Ye
Bao-hui Han
机构：
[1] Shanghai Chest Hospital,Department of Pulmonary Medicine
[2] Shanghai Jiao Tong University,undefined
[3] Institutes of Biomedical Sciences,undefined
[4] Fudan University,undefined
来源：
Acta Pharmacologica Sinica | 2016年 / 37卷
关键词：
NSCLC; platinum-based chemotherapy; polymorphisms; gastrointestinal toxicity; hematological toxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1490 / 1498
页数：8
相关论文
共 50 条
  • [21] A slow disengagement from platinum-based chemotherapy for patients with advanced non-small cell lung cancer
    Ballas, MS
    Dennis, PA
    CANCER BIOLOGY & THERAPY, 2005, 4 (12) : 1316 - 1317
  • [22] Efficacy of platinum-based chemotherapy in patients with non-small cell lung cancer and synchronous brain metastasis
    Oscar, Gallego
    Cinta, Pallares
    Margarita, Majem
    Nuria, Farre
    Gemma, Carreras
    Raquel, Marse
    Xavier, Gonzalez
    Julen, Fernandez
    David, Paez
    Lopez, Juan Jose
    ANNALS OF ONCOLOGY, 2006, 17 : 238 - 238
  • [23] Is the platinum-based chemotherapy necessary for elderly patients with advanced non-small cell lung cancer (NSCLC)?
    Daga, H.
    Takeda, K.
    Kiyota, H.
    Tokunaga, S.
    Nanjo, S.
    Sumitani, M.
    Shoji, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [24] Echocardiography and cardiac biomarkers in patients with non-small cell lung cancer treated with platinum-based chemotherapy
    Omersa, Daniel
    Cufer, Tanja
    Marcun, Robert
    Lainscak, Mitja
    RADIOLOGY AND ONCOLOGY, 2017, 51 (01) : 15 - 22
  • [25] Role of DNA Repair Gene Polymorphisms in the Efficiency of Platinum-Based Adjuvant Chemotherapy for Non-Small Cell Lung Cancer
    Mathiaux, Juliette
    Le Morvan, Valerie
    Pulido, Marina
    Jougon, Jacques
    Begueret, Hugues
    Robert, Jacques
    MOLECULAR DIAGNOSIS & THERAPY, 2011, 15 (03) : 159 - 166
  • [26] Role of DNA Repair Gene Polymorphisms in the Efficiency of Platinum-Based Adjuvant Chemotherapy for Non-Small Cell Lung Cancer
    Juliette Mathiaux
    Valérie Le Morvan
    Marina Pulido
    Jacques Jougon
    Hugues Bégueret
    Jacques Robert
    Molecular Diagnosis & Therapy, 2011, 15 : 159 - 166
  • [27] Pharmacogenetics of platinum-based chemotherapy in non-small cell lung cancer: predictive validity of polymorphisms of ERCC1
    Hamilton, Gerhard
    Rath, Barbara
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (01) : 17 - 24
  • [28] Association between ERCC1 polymorphisms and nephrotoxicity in non-small cell lung cancer patients undergoing platinum-based chemotherapy
    de Jong, Corine
    Deneer, Vera Henriette
    Kelder, Johannes
    Hunting, Cornelis Bernardus
    Herder, Gerarda
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [29] Association of Bcl2 family gene polymorphisms with response to and toxicity of platinum-based chemotherapy in non-small-cell lung cancer patients in a Chinese population
    Qian, Ji
    Wu, Qi Han
    Lu, Da Ru
    Wei, Qing Yi
    CANCER RESEARCH, 2011, 71
  • [30] Differences In Toxicity Among Platinum-Based Combinations As Reported By Non-Small Cell Lung Cancer (NSCLC) Patients
    Kosmidis, P.
    Deligianni, E.
    Lagogianni, C.
    Kosmidis, T.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S502 - S503
12345